VesselMetaKAN: A Two-Stage Framework for Interpretable Classification of Diabetic Retinopathy Using Vessel Guidance and Meta-Learning
-
By
-
TianQi Yang
-
GuoYong Chen
-
Lu Liu
-
July 16, 2026
Clinical Report: VesselMetaKAN Framework for Diabetic Retinopathy Classification
Overview
VesselMetaKAN is a two-stage framework designed for the interpretable classification of diabetic retinopathy (DR) using vessel guidance and meta-learning. It achieved significant performance metrics on the APTOS 2019 dataset.
Background
Diabetic retinopathy is a major cause of preventable blindness, affecting millions globally. Early detection through automated grading systems is essential for effective public health interventions. However, existing deep learning methods face challenges in accurately identifying vascular structures critical for DR diagnosis.
Data Highlights
| Metric | Value |
|---|---|
| Accuracy | 74.9 ± 0.4% |
| Macro-F1 | 58.7 ± 0.6% |
| QWK | 0.838 ± 0.005 |
| Best Single Run Accuracy | 75.44% |
| Best Single Run Macro-F1 | 59.44% |
| Best Single Run QWK | 0.843 |
Key Findings
- VesselMetaKAN integrates vessel guidance with meta-learning for DR classification.
- Stage 1 utilizes GMF-SwinUnet for vessel segmentation with advanced techniques like Frangi-guided attention fusion.
- Stage 2 employs KAN-MAML for interpretable decision-making and meta-learning.
- Ablation studies confirmed the importance of vessel guidance and KAN-based interpretability.
- VesselMetaKAN outperformed EfficientNet-B4 in key grading metrics with statistical significance (p < 0.05).
Clinical Implications
The VesselMetaKAN framework offers a robust and interpretable solution for diabetic retinopathy grading, addressing critical challenges in vessel segmentation and feature learning.
Conclusion
VesselMetaKAN represents a significant advancement in automated diabetic retinopathy classification, combining interpretability with high performance.
Related Resources & Content
- Frontiers in Medicine, 2026 -- AI-driven saliency-guided retinal vessel segmentation framework for sustainable digital pathology
- Frontiers in Medicine, 2026 -- Detection of Referable Diabetic Retinopathy using Machine Learning on Routine Clinical Data
- Frontiers in Endocrinology, 2026 -- Diagnostic accuracy and clinical performance of deep learning models for grading diabetic retinopathy: a systematic review and meta-analysis
- npj Digital Medicine -- Advanced Geometric-Topological Transfer Learning Techniques for Accurate Vessel Segmentation in Three-Dimensional Medical Imaging
- Diabetes Care, 2026 -- Children and Adolescents: Standards of Care in Diabetes
- PMC -- Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial
- International Journal of Retina and Vitreous -- The efficacy of artificial intelligence in diabetic retinopathy screening: a systematic review and meta-analysis
- 14. Children and Adolescents: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
- Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial - PMC
- The efficacy of artificial intelligence in diabetic retinopathy screening: a systematic review and meta-analysis | International Journal of Retina and Vitreous | Springer Nature Link
Based on findings from:
VesselMetaKAN: vessel-guided meta-learned interpretable classification for diabetic retinopathy grading
TianQi Yang, GuoYong Chen, Lu Liu. Frontiers In Medicine, 2026.
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1846788/full
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.